Organon is set to acquire Roivant Sciences' Dermavant Sciences, known for developing immuno-dermatology treatments, including FDA-approved Vtama cream for plaque psoriasis. The deal, valued up to $1.2 billion. read more
Roivant Sciences Offloads Psoriasis Medicine Maker To Organon For Up To $1.2B